Related references
Note: Only part of the references are listed.Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome
Xuan Yuan et al.
HAEMATOLOGICA (2017)
Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome
Xuan Yuan et al.
HAEMATOLOGICA (2017)
Analysis of Factor D Isoforms in Malpuech-Michels-Mingarelli-Carnevale Patients Highlights the Role of MASP-3 as a Maturase in the Alternative Pathway of Complement
Rasmus Pihl et al.
JOURNAL OF IMMUNOLOGY (2017)
Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses
Xiaoguang Xue et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
Properdin binding to complement activating surfaces depends on initial C3b deposition
Morten Harboe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses
Xiaoguang Xue et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
The lectin self of complement factor H
Baerbel S. Blaum
CURRENT OPINION IN STRUCTURAL BIOLOGY (2017)
Functional and structural insight into properdin control of complement alternative pathway amplification
Dennis V. Pedersen et al.
EMBO JOURNAL (2017)
Regulation of the mouse adipose Factor D biosynthesis by the endocrine hypothalamic-pituitary-adrenal axis
Xiaobo Wu et al.
IMMUNOBIOLOGY (2016)
The complement factor H-related proteins
Nicholas Medjeral-Thomas et al.
IMMUNOLOGICAL REVIEWS (2016)
Small-molecule factor D inhibitors targeting the alternative complement pathway
Jurgen Maibaum et al.
NATURE CHEMICAL BIOLOGY (2016)
Hybrid mass spectrometry approaches in glycoprotein analysis and their usage in scoring biosimilarity
Yang Yang et al.
NATURE COMMUNICATIONS (2016)
MASP-3 is the exclusive pro-factor D activator in resting blood: the lectin and the alternative complement pathways are fundamentally linked
Jozsef Dobo et al.
SCIENTIFIC REPORTS (2016)
Molecular insights into the surface-specific arrangement of complement C5 convertase enzymes
Evelien T. M. Berends et al.
BMC BIOLOGY (2015)
Is the Complement Activation Product C3a a Proinflammatory Molecule? Re-evaluating the Evidence and the Myth
Liam G. Coulthard et al.
JOURNAL OF IMMUNOLOGY (2015)
Factor H-related proteins determine complement-activating surfaces
Mihaly Jozsi et al.
TRENDS IN IMMUNOLOGY (2015)
A Novel Atypical Hemolytic Uremic Syndrome-Associated Hybrid CFHR1/CFH Gene Encoding a Fusion Protein That Antagonizes Factor H-Dependent Complement Regulation
Elisabetta Valoti et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo
M. M. Ruseva et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Identification of Factor H-like Protein 1 as the Predominant Complement Regulator in Bruch's Membrane: Implications for Age-Related Macular Degeneration
Simon J. Clark et al.
JOURNAL OF IMMUNOLOGY (2014)
Complement Nomenclature 2014
Claudia Kemper et al.
MOLECULAR IMMUNOLOGY (2014)
Human Factor H-Related Protein 2 (CFHR2) Regulates Complement Activation
Hannes U. Eberhardt et al.
PLOS ONE (2013)
Dimerization of complement factor H-related proteins modulates complement activation in vivo
Elena Goicoechea de Jorge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The tick-over theory revisited: Is C3 a contact-activated protein?
Bo Nilsson et al.
IMMUNOBIOLOGY (2012)
Mannan-Binding Lectin-Associated Serine Protease (MASP)-1 Is Crucial for Lectin Pathway Activation in Human Serum, whereas neither MASP-1 nor MASP-3 Is Required for Alternative Pathway Function
Soren E. Degn et al.
JOURNAL OF IMMUNOLOGY (2012)
The Role of Properdin in Zymosan- and Escherichia coli-Induced Complement Activation
Morten Harboe et al.
JOURNAL OF IMMUNOLOGY (2012)
Native Properdin Binds to Chlamydia pneumoniae and Promotes Complement Activation
Claudio Cortes et al.
INFECTION AND IMMUNITY (2011)
Mechanisms of mannose-binding lectin-associated serine proteases-1/3 activation of the alternative pathway of complement
Nirmal K. Banda et al.
MOLECULAR IMMUNOLOGY (2011)
Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk
Meike Heurich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement
Tommi Kajander et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Use of time-resolved FRET to validate crystal structure of complement regulatory complex between C3b and factor H (N terminus)
Isabell C. Pechtl et al.
PROTEIN SCIENCE (2011)
Linkage Specificity and Role of Properdin in Activation of the Alternative Complement Pathway by Fungal Glycans
Sarika Agarwal et al.
MBIO (2011)
Properdin: Emerging Roles of a Pattern-Recognition Molecule
Claudia Kemper et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Essential role of Mannose-binding lectin-associated serine protease-1 in activation of the complement factor D
Minoru Takahashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation
Stefan Heinen et al.
BLOOD (2009)
Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement
Yuko Kimura et al.
BLOOD (2008)
The spectrum of complement alternative pathway-mediated diseases
V. Michael Holers
IMMUNOLOGICAL REVIEWS (2008)
Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation
Wei Xu et al.
JOURNAL OF IMMUNOLOGY (2008)
The tick-over theory revisited:: Formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb)
Fredrik Bexborn et al.
MOLECULAR IMMUNOLOGY (2008)
Translational Mini-Review Series on Complement Factor H: Therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis
M. Noris et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Translational mini-review series on complement factor H: Structural and functional correlations for factor H
C. Q. Schmidt et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Complement driven by conformational changes
Piet Gros et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Opinion paper: Stimulation of complement amplification or activation of the alternative pathway of complement?
Hans U. Lutz et al.
MOLECULAR IMMUNOLOGY (2007)
Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly
Dirk Spitzer et al.
JOURNAL OF IMMUNOLOGY (2007)
Factor B structure provides insights into activation of the central protease of the complement system
Fin J. Milder et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces
Viviana P. Ferreira et al.
JOURNAL OF IMMUNOLOGY (2006)
The role of properdin in the assembly of the alternative pathway C3 convertases of complement
DE Hourcade
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Genetic and environmental factors influencing the human factor H plasma levels
J Esparza-Gordillo et al.
IMMUNOGENETICS (2004)
Multiple ligand binding sites on domain seven of human complement factor H
E Giannakis et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
Different regulation of factor H and FHL-1/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA)
MA Friese et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
Activation of the alternative pathway of human complement by autologous cells expressing transmembrane recombinant properdin
BB Vuagnat et al.
MOLECULAR IMMUNOLOGY (2000)